This bill amends existing laws regarding the use of telemedicine for prescribing non-opioid and opioid controlled drugs classified in schedules II through IV. It allows not only physicians but also physician assistants and advanced practice registered nurses (APRN) to prescribe these medications via telemedicine. The bill modifies the requirement for a subsequent evaluation, replacing the term "in-person exam" with "evaluation," and mandates that this evaluation be conducted at intervals appropriate for the patient, medical condition, and drug, but not less than annually. Additionally, it clarifies that all prescribing must comply with federal and state laws and regulations.

The bill specifically inserts provisions that authorize physician assistants and APRNs to prescribe controlled substances through telemedicine, ensuring that they follow the same evaluation requirements as physicians. The new language emphasizes the importance of ongoing patient assessments while expanding the scope of practice for these healthcare providers. The act is set to take effect 60 days after its passage, which is scheduled for August 23, 2025.

Statutes affected:
Introduced: 329:1-d
As Amended by the Senate: 329:1-d, 328-D:3-b, 326-B:11
Version adopted by both bodies: 329:1-d, 328-D:3-b, 326-B:11
CHAPTERED FINAL VERSION: 329:1-d, 328-D:3-b, 326-B:11